Supercapsular Percutaneously Assisted Total Hip Approach for the Elderly With Femoral Neck Fractures

NCT ID: NCT03134664

Last Updated: 2017-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To test that the SuperPATH approach is more safe and reliable for hip functional recovery compared with the postolateral approach in the artificial hip replacement for femoral neck fractures in the elderly.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Femoral neck fracture is one of the most common diseases in the elderly. Artificial hip replacement is currently the preferred treatment for femoral neck fractures, and characterized by no presence of postoperative bone nonunion, femoral head necrosis and other complications, though longer operative time and larger surgical incision are unavoidable. Patients undergoing artificial hip replacement can recover weight-bearing walk early after surgery, making rehabilitation rapid, to avoid a variety of complications, such as bed rests. Hip replacement via posterolateral approach is generally used, but limited by large incision, cutting off the extortor, and postoperative hip dislocation.

The minimally invasive approach for hip replacement has the advantages of less blood loss and less trauma compared with conventional approaches. The supercapsular percutaneously-assisted total hip (SuperPATH) approach (Appendix 1) is consistent with the posterolateral approach in the anatomical landmark, preserving all the advantages of the posterior approach. Compared with the conventional approaches, the SuperPATH approach has no neurovascular interface that is uneasy to damage blood vessels and nerves during operation, reducing intraoperative blood loss, and retains all of the joint capsules and supinator muscles, significantly reducing the probability of postoperative dislocation of the hip. Osteotomy via this approach can be completed without hip dislocation, thus reducing incidence of vascular distortion and postoperative deep vein thrombosis. Hip replacement via the SuperPATH approach can be completed under direct vision rather than perspective inspection, and the surgical incision on the femur is made according to the femoral anteversion angle. In addition, this approach is also used for femoral intramedullary nail implantation. These surgical procedures are more likely to be grasped by clinicians. Preservation of the joint capsule and supinator muscles makes physical activities unrestricted and speeds up rehabilitation. Moreover, there is a corresponding reduction in the hospital stay and costs. However, SuperPATH technology is rarely reported in China as it has been introduced for a short time and in few hospitals.

Previous studies have reported that SuperPATH approach for artificial hip replacement exhibits better short-term effect on elderly femoral neck fractures. In this trial, the follow-up period will be prolonged to 6 months in order to observe the short-to-mid term effect in the elderly with femoral neck fractures.

Adverse events Postoperative adverse events including incision pain and infection, back muscle pain, spinal cord/nerve injury, length inequality of the lower limbs, prosthesis falling-off and prosthetic loosening will be recorded during the follow-up period. If severe adverse events occur, details including the data of occurrence, type of adverse events and therapeutic measures will be reported to the project manager and the institutional review board within 24 hours.

Data collection, management, analysis, and open access Data collection Clinical data, including demographic data, disease diagnosis, accompanying diseases, and allergic history (drug allergy), will be collected and summarized using standardized case report forms. These data will be processed and recorded electronically.

Data management Researchers will be responsible for data processing, confirming and locking. The locked data will be unable to be altered and preserved by the Pudong Hospital of Fudan University. In addition to these researchers, only the persons who have permission will have the right to query the database.

Data analysis All data will be statistically analyzed by professional statisticians who will responsible for completing an outcome analysis report that will be submitted to the principle investigator who will be responsible for completing a research report. An independent data monitoring committee is responsible for data monitoring and management throughout the entire trial to ensure scientific accuracy, stringency, authenticity, and integrity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoral Neck Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Forty patients with femoral neck fractures admitted at Pudong Hospital of Fudan University, China are randomly divided into two groups.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the SuperPATH approach in the experimental group.

Group Type EXPERIMENTAL

Experimental group

Intervention Type PROCEDURE

Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the SuperPATH approach in the experimental group.

Control group

Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the conventional posterior approach in the control group.

Group Type EXPERIMENTAL

Control group

Intervention Type PROCEDURE

Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the conventional posterior approach in the control group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental group

Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the SuperPATH approach in the experimental group.

Intervention Type PROCEDURE

Control group

Patients with femoral neck fractures are randomly assigned to undergo femoral head replacement via the conventional posterior approach in the control group.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Femoral head fractures as diagnosed by X-ran and CT;
* Garden III, IV;
* An age of \> 75 years;
* Both genders.

Exclusion Criteria

* Fractures with spinal cord injury;
* Fractures with nerve injury;
* Refusal to sign the informed consent.
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Pudong Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lianghao Wu, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Pudong Hospital of Fudan University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ShanghaiPudongH_002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.